Skip to main content

Table 3 Relationship of triglyceride level with all-cause mortality in coronary artery disease and subgroupsa

From: The triglyceride paradox in the mortality of coronary artery disease

 

All-Cause Mortality

 

Cardiovascular Mortality

 

HR (95% CI)

p

HR (95% CI)

p

Total patients

 Unadjusted

0.74 (0.62–0.87)

<  0.001

0.77 (0.60–0.97)

0.028

 Adjustedb

0.71 (0.58–0.86)

0.001

0.67 (0.51–0.89)

0.006

ACS

 Unadjusted

0.71 (0.60–0.88)

0.001

0.80 (0.61–1.04)

0.096

 Adjustedb

0.72 (0.58–0.90)

0.003

0.69 (0.51–0.94)

0.018

AMI

 Unadjusted

0.63 (0.46–0.87)

0.005

0.53 (0.33–0.85)

0.008

 Adjustedb

0.71 (0.50–1.01)

0.057

0.51 (0.30–0.86)

0.012

Stable angina pectoris

 Unadjusted

0.74 (0.52–1.06)

0.099

0.62 (0.36–1.06)

0.086

 Adjustedb

0.61 (0.39–0.95)

0.028

0.59 (0.24–1.16)

0.127

  1. Abbreviations: HR hazard ratio, CI confidence interval, ACS acute coronary syndrome, AMI acute myocardial infarction, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, CAD coronary artery disease, BMI body mass index, GRACE score Global Registry of Acute Coronary Events score
  2. aTriglyceride levels was grouped by the tertiles; bRisk factors adjustment included age, sex, medical history (pre-hypertension, pre-diabetes mellitus, pre-myocardial infarction, pre-PCI and pre-CABG), admission examination (systolic blood pressure, heart rate, BMI and GRACE score), admission lab test (blood glucose, serum creatinine, LDL-C and HDL-C), and severity of CAD (left main artery, three vessel diseases and number of stents)